chr3-96814839-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001080448.3(EPHA6):c.216C>T(p.Thr72=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00301 in 1,578,330 control chromosomes in the GnomAD database, including 97 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.013 ( 46 hom., cov: 31)
Exomes 𝑓: 0.0019 ( 51 hom. )
Consequence
EPHA6
NM_001080448.3 synonymous
NM_001080448.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.758
Genes affected
EPHA6 (HGNC:19296): (EPH receptor A6) Predicted to enable transmembrane-ephrin receptor activity. Predicted to be involved in axon guidance; positive regulation of kinase activity; and transmembrane receptor protein tyrosine kinase signaling pathway. Located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 3-96814839-C-T is Benign according to our data. Variant chr3-96814839-C-T is described in ClinVar as [Benign]. Clinvar id is 778089.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.758 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0134 (2035/152162) while in subpopulation AFR AF= 0.0442 (1834/41536). AF 95% confidence interval is 0.0425. There are 46 homozygotes in gnomad4. There are 932 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High AC in GnomAd4 at 2035 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EPHA6 | NM_001080448.3 | c.216C>T | p.Thr72= | synonymous_variant | 1/18 | ENST00000389672.10 | NP_001073917.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EPHA6 | ENST00000389672.10 | c.216C>T | p.Thr72= | synonymous_variant | 1/18 | 1 | NM_001080448.3 | ENSP00000374323 | P1 | |
EPHA6 | ENST00000506569.1 | c.51C>T | p.Thr17= | synonymous_variant | 1/4 | 1 | ENSP00000425132 | |||
EPHA6 | ENST00000470610.6 | c.216C>T | p.Thr72= | synonymous_variant | 1/5 | 2 | ENSP00000420598 |
Frequencies
GnomAD3 genomes AF: 0.0133 AC: 2027AN: 152044Hom.: 46 Cov.: 31
GnomAD3 genomes
AF:
AC:
2027
AN:
152044
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00406 AC: 763AN: 187906Hom.: 18 AF XY: 0.00334 AC XY: 337AN XY: 100852
GnomAD3 exomes
AF:
AC:
763
AN:
187906
Hom.:
AF XY:
AC XY:
337
AN XY:
100852
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00190 AC: 2715AN: 1426168Hom.: 51 Cov.: 35 AF XY: 0.00175 AC XY: 1237AN XY: 706362
GnomAD4 exome
AF:
AC:
2715
AN:
1426168
Hom.:
Cov.:
35
AF XY:
AC XY:
1237
AN XY:
706362
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0134 AC: 2035AN: 152162Hom.: 46 Cov.: 31 AF XY: 0.0125 AC XY: 932AN XY: 74394
GnomAD4 genome
AF:
AC:
2035
AN:
152162
Hom.:
Cov.:
31
AF XY:
AC XY:
932
AN XY:
74394
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
9
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 05, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at